INFI - Infinity Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2017)Next Qtr. (Dec 2017)Current Year (2017)Next Year (2018)
No. of Analysts4444
Avg. Estimate-0.21-0.2-0.92-1.5
Low Estimate-0.22-0.22-0.98-2.94
High Estimate-0.18-0.15-0.73-0.91
Year Ago EPS-0.39-0.46-0.61-0.92
Revenue EstimateCurrent Qtr. (Sep 2017)Next Qtr. (Dec 2017)Current Year (2017)Next Year (2018)
No. of Analysts4444
Avg. Estimate14.7M14.7M29.38M29.68M
Low EstimateN/AN/AN/AN/A
High Estimate58.8M58.8M117.5M118.7M
Year Ago SalesN/AN/A18.72M29.38M
Sales Growth (year/est)N/AN/A56.90%1.00%
Earnings History9/29/201612/30/20163/30/20176/29/2017
EPS Est.-0.85-0.57-0.27-0.2
EPS Actual-0.39-0.46-0.21-0.34
Difference0.460.110.06-0.14
Surprise %54.10%19.30%22.20%-70.00%
EPS TrendCurrent Qtr. (Sep 2017)Next Qtr. (Dec 2017)Current Year (2017)Next Year (2018)
Current Estimate-0.21-0.2-0.92-1.5
7 Days Ago-0.21-0.2-0.92-1.5
30 Days Ago-0.21-0.2-0.92-1.5
60 Days Ago-0.2-0.2-0.89-1.5
90 Days Ago-0.2-0.19-0.84-1.42
EPS RevisionsCurrent Qtr. (Sep 2017)Next Qtr. (Dec 2017)Current Year (2017)Next Year (2018)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Down Last 90 DaysN/AN/AN/AN/A
Growth EstimatesINFIIndustrySectorS&P 500
Current Qtr.46.20%N/AN/A0.15
Next Qtr.56.50%N/AN/A0.27
Current Year-50.80%N/AN/A0.07
Next Year-63.00%N/AN/A0.12
Next 5 Years (per annum)89.63%N/AN/A0.10
Past 5 Years (per annum)19.94%N/AN/AN/A